- CA$243.38m
- CA$216.35m
- $56.08m
- 60
- 19
- 88
- 56
Annual income statement for Q4, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.3 | 22.4 | 40.4 | 55.4 | 56.1 |
Cost of Revenue | |||||
Gross Profit | 9.2 | 12 | 21.7 | 31.6 | 33.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.8 | 32.3 | 52.6 | 77.6 | 93.4 |
Operating Profit | -4.45 | -9.9 | -12.2 | -22.2 | -37.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.95 | -10.9 | -12.9 | -26.8 | -36.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.27 | -11.1 | -13.1 | -26.9 | -36.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.27 | -11.1 | -13.1 | -26.9 | -36.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.27 | -11.1 | -13.1 | -26.9 | -36.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.207 | -0.275 | -0.329 | -1.7 | -0.863 |
Dividends per Share |